Lutonix® Global AV Registry Investigating Lutonix Drug Coated Balloon for Treatment of Native and Synthetic AV Fistulae

CompletedOBSERVATIONAL
Enrollment

320

Participants

Timeline

Start Date

June 7, 2016

Primary Completion Date

September 18, 2018

Study Completion Date

March 9, 2019

Conditions
Arteriovenous Fistula
Interventions
DEVICE

Lutonix 035 Drug Coated Balloon PTA Catheter, Model 9004

Trial Locations (26)

6903

Ospedale Regionale di Lugano, Lugano

21100

University of Insubria, Varese

26504

University Hospital of Patras, Pátrai

35392

Uniklinik Giessen und Marburg, Giessen

72018

Clinique du Pré, Le Mans

75014

Institut Montsouris, Paris

77000

Clinique Les Fontaines, Melun

80045

Casa Di Cura Maria Rosaria, Pompei

119228

National University Hospital, Singapore

169856

Singapore General Hospital, Singapore

A-8036

LKH Graz, Graz

07743

Universitätsklinikum Jena, Jena

Unknown

Azienda Ospedaliera Di Pisa - Ospedale Cisanello, Pisa

San Giovanni Bosco, Torino

King Abdullah International Medical Research Center, Riyadh

Buddhist Dalin Tzuchi hospital, Dalin

Chang-Gung Memorial Hospital, Linkou District

Hsin Kong Wu Ho-Su Memorial Hospital, Taipei

Taipei Tzu Chi Hospital, Taipei

Ankara Baskent University, Ankara

20-081

Klinika Chirurgii Naczyniowej University Hospital nr 1, Lublin

1549-008

Hospital da Cruz Vermelha, Lisbon

1750-130

NephroCare Portugal, S.A. NephroCare Lumia, Lisbon

SG1 4AB

Lister Hospital, Leicester

E1 1BB

Barts and The Royal London Hospital, London

RG1 5AN

Royal Berkshire hospital, Reading

Sponsors

Lead Sponsor

All Listed Sponsors
lead

C. R. Bard

INDUSTRY

NCT02746159 - Lutonix® Global AV Registry Investigating Lutonix Drug Coated Balloon for Treatment of Native and Synthetic AV Fistulae | Biotech Hunter | Biotech Hunter